Cascadia Capital Advises Cytozyme in Acquisition by Verdesian

Cytozyme Laboratories, Inc. Logo has been acquired by Verdesian Life Sciences Logo

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Cytozyme Laboratories, Inc. (“Cytozyme”) a leading manufacturer and provider of agricultural nutritional products, in its acquisition by Verdesian Life Sciences (“Verdesian”).

Since 1975, Cytozyme has empowered progressive growers around the world to achieve sustainable yield and quality increases through high performance crop solutions. The company’s naturally derived products help to ensure optimal food production, grower profitability, and environmental health.

Verdesian is a leader in developing patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies.

“For more than four decades, Cytozyme’s mission has been to help farmers achieve sustainable yields through innovative solutions,” said Cytozyme CEO Eric Baughman. “We firmly believe that Verdesian Life Sciences has the technology, capabilities, and the people to continue that mission in a way that is true to our ideals. The product mixes of our two companies are incredibly complementary; this is a great day for growers everywhere.”

“Cascadia was a committed partner in the process and helped in achieving a successful outcome for all stakeholders,” Baughman added.

“This transaction represents the increasing desire of growers for sustainable crop solutions,” said Scott Porter, Managing Director of Cascadia’s Agribusiness team. “The market for sustainable and efficacious crop technologies remains in its infancy and the future opportunity is significant. Cascadia is dedicated to supporting leading agricultural input companies as they seek to address this market opportunity.”

George Sent, Managing Director of Cascadia, added, “We were pleased to work with the shareholders to find the right partner to take Cytozyme to the next level. Cytozyme offers such a unique array of crop input technologies, it still has substantial untapped potential to be realized over the next decade.”

The acquisition represents another successful transaction for Cascadia in the Agriculture sector. Past transactions include the sale of GreenVenus to Third Security, LLC, the acquisition of Specialty Sales, LLC by Benford Capital, and Auvil Fruit’s investment from Fiera Comox.

For more information about this transaction, please contact the Cascadia Capital deal team:

George Sent
Managing Director
(206) 436-2511

Scott Porter
Managing Director
(206) 436-2528

Or other senior members of the Cascadia Food, Beverage & Agribusiness practice:

Michael Butler
Chairman & CEO
(206) 436-2530

Erik Einwalter
Managing Director
(206) 436-2538

Bryan Jaffe
Managing Director
(206) 436-2534

Back to News